Late-Breaking Clinical Trials (LBCT) debut at HRX Live 2026 as an inaugural program.
Presentations will spotlight First-in-Human and Early Feasibility studies at the moment they begin to influence thinking, discussion, and decision-making across electrophysiology and cardiovascular innovation.
LBCT submissions open June 1, 2026 and close July 10, 2026. Register by May 6 to save with early bird pricing.